Chin Med J (Engl)
August 2013
Background: Cancer stem cells (CSCs) are the cause of cancer recurrence because they are resistant to conventional therapy and contribute to cancer growth and metastasis. Endocrinotherapy is the most common breast cancer therapy and acquired tamoxifen (TAM) resistance is the main reason for endocrinotherapy failure during such therapy. Although acquired resistance to endocrine treatment has been extensively studied, the underlying mechanisms are unclear.
View Article and Find Full Text PDFAsian Pac J Trop Med
September 2013
Zhonghua Yi Xue Za Zhi
January 2013